Uzbekistan Partners With UAE’s Advanced Technology Research Council to Accelerate Falcon AI Adoption
ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--The UAE’s Advanced Technology Research Council (ATRC), mandated to shape…
2 years ago
Korean Government Delegation and KACES Conclude Successful 3rd UNESCO World Conference on Culture and Art Education
The world's leading conference on culture and arts education held in 14 years The global…
2 years ago
LTIMindtree Unveils Navisource.AI: Revolutionizing Procurement CoPilot on Canvas.AI Platform
The platform boosts productivity by 20% and reduces overall procurement cost by 10-15% WARREN, N.J.…
2 years ago
2035 E-Mobility Taiwan: The Platform Shaping the Future of Mobility
TAIPEI, TAIWAN - Media OutReach Newswire - 19 February 2024 - 2035 E-Mobility Taiwan, Taiwan's…
2 years ago
NEC and D-Wave Introduce New Quantum Offerings to Australian Market
SYDNEY & PALO ALTO, Calif. & BURNABY, British Columbia--(BUSINESS WIRE)--NEC Australia and leading international quantum…
2 years ago
Melco Style Presents: The Black Pearl Diamond Restaurants Gastronomic Series to Commence the 2024 Events this March
Tickets for the YÃ x Xujiacai, Bi Ying x Huaiyangfu, and Aurora x Amico BJ…
2 years ago
Arcitecta Honored for Advanced Data Management Solution that Delivers High-speed File Transfers over Vast Distances and High Latency Networks
Mediaflux Livewire Named “Most Complete Architecture†by the International Data Mover Challenge at SCA24 MELBOURNE,…
2 years ago
Arcitecta Unveils New Capabilities for Cross-Global Collaboration, Allowing Customers to Focus on the Value of Data, Not Its Management
Cutting-edge Data Management Software Provider Solves the Problems of Large-scale Data Transmission over Slow, Undependable…
2 years ago
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
BEIJING--(BUSINESS WIRE)--#Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogenâ€, HKEX: 02315) today announces an antibody evaluation and…
2 years ago
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Application based on results from the TROPION-Lung01 phase 3 trial If approved, Daiichi Sankyo and…
2 years ago